z-logo
open-access-imgOpen Access
Ciprofloxacin-induced persister-cells in Campylobacter jejuni
Author(s) -
Armen Ovsepian,
Mona Larsen,
Christina S. Vegge,
Hanne Ingmer
Publication year - 2020
Publication title -
microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 179
eISSN - 1465-2080
pISSN - 1350-0872
DOI - 10.1099/mic.0.000953
Subject(s) - multidrug tolerance , ciprofloxacin , campylobacter jejuni , microbiology and biotechnology , biology , antibiotics , bacteria , ampicillin , campylobacter , biofilm , genetics
Campylobacter jejuni is a major bacterial foodborne-pathogen. Ciprofloxacin is an important antibiotic for the treatment of C. jejuni , albeit high rates of fluoroquinolone resistance have limited its usefulness. Persister-cells are transiently antibiotic-tolerant fractions of bacterial populations and their occurrence has been associated with recalcitrant and persistent bacterial infections. Here, time-kill assays with ciprofloxacin (200×MIC, 25 µg ml −1 ) were performed in C. jejuni strains 81–176 and RM1221 and persister-cells were found. The frequency of survivors after 8 h of ciprofloxacin exposure was approx. 10 −3 for both strains, while after 22 h the frequency was between 10 −5 –10 −7 , depending on the strain and growth-phase. Interestingly, the stationary-phase cultures did not display more persister-cells compared to exponential-phase cultures, in contrast to what has been observed in other bacterial species. Persister-cells after ampicillin exposure (100×MIC, 200 µg ml −1 ) were not detected, implying that persister-cell formation in C. jejuni is antibiotic-specific. In attempts to identify the mechanism of ciprofloxacin persister-cell formation, stringent or SOS responses were not found to play major roles. Overall, this study reports ciprofloxacin persister-cells in C. jejuni and challenges the notion of persister-cells as plainly dormant non-growing cells.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here